HK1031387A1 - Purification of molecules - Google Patents

Purification of molecules

Info

Publication number
HK1031387A1
HK1031387A1 HK01100970A HK01100970A HK1031387A1 HK 1031387 A1 HK1031387 A1 HK 1031387A1 HK 01100970 A HK01100970 A HK 01100970A HK 01100970 A HK01100970 A HK 01100970A HK 1031387 A1 HK1031387 A1 HK 1031387A1
Authority
HK
Hong Kong
Prior art keywords
contaminants
molecules
molecule
purification
column
Prior art date
Application number
HK01100970A
Other languages
English (en)
Inventor
Robert L Fahrner
David Reifsnyder
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1031387A1 publication Critical patent/HK1031387A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK01100970A 1997-10-24 2001-02-09 Purification of molecules HK1031387A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95776097A 1997-10-24 1997-10-24
PCT/US1998/021238 WO1999021889A1 (en) 1997-10-24 1998-10-08 Purification of molecules

Publications (1)

Publication Number Publication Date
HK1031387A1 true HK1031387A1 (en) 2001-06-15

Family

ID=25500093

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100970A HK1031387A1 (en) 1997-10-24 2001-02-09 Purification of molecules

Country Status (13)

Country Link
EP (1) EP1025126B1 (xx)
JP (1) JP4239131B2 (xx)
AT (1) ATE237636T1 (xx)
AU (1) AU740665B2 (xx)
CA (1) CA2306447C (xx)
DE (1) DE69813599T2 (xx)
DK (1) DK1025126T3 (xx)
ES (1) ES2195409T3 (xx)
HK (1) HK1031387A1 (xx)
IL (1) IL135087A (xx)
PT (1) PT1025126E (xx)
WO (1) WO1999021889A1 (xx)
ZA (1) ZA989424B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002316811A1 (en) 2001-06-28 2003-03-03 Novo Nordisk A/S Stable formulation of modified glp-1
JP4936884B2 (ja) 2003-06-03 2012-05-23 ノボ・ノルデイスク・エー/エス 安定化された薬学的ペプチド組成物
PL1633391T3 (pl) 2003-06-03 2012-03-30 Novo Nordisk As Stabilizowane farmaceutycznie kompozycje peptydowe
PL1687019T3 (pl) 2003-11-20 2018-05-30 Novo Nordisk A/S Formulacje peptydowe zawierające glikol propylenowy, które są optymalne do produkcji i do zastosowania w urządzeniach do wstrzykiwań
PL1789434T3 (pl) * 2004-08-31 2014-07-31 Novo Nordisk As Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
MX2007005521A (es) 2004-11-12 2007-05-18 Novo Nordisk As Formulaciones estables de peptidos insulinotropicos.
US8921518B2 (en) 2005-12-23 2014-12-30 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (RPC)
US9488625B2 (en) 2010-12-15 2016-11-08 Baxalta GmbH Purification of factor VIII using a conductivity gradient
AR112480A1 (es) 2017-08-24 2019-10-30 Novo Nordisk As Composiciones de glp-1 y sus usos
KR20220143037A (ko) 2020-02-18 2022-10-24 노보 노르디스크 에이/에스 Glp-1 조성물 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US5446024A (en) * 1993-12-17 1995-08-29 Genentech, Inc. Purification of insulin-like growth factor

Also Published As

Publication number Publication date
ZA989424B (en) 2000-04-17
AU740665B2 (en) 2001-11-08
ES2195409T3 (es) 2003-12-01
AU1072599A (en) 1999-05-17
PT1025126E (pt) 2003-09-30
EP1025126A1 (en) 2000-08-09
JP2001521044A (ja) 2001-11-06
DE69813599D1 (de) 2003-05-22
JP4239131B2 (ja) 2009-03-18
IL135087A (en) 2005-05-17
CA2306447C (en) 2009-04-07
ATE237636T1 (de) 2003-05-15
WO1999021889A1 (en) 1999-05-06
DK1025126T3 (da) 2003-08-04
DE69813599T2 (de) 2004-04-08
EP1025126B1 (en) 2003-04-16
CA2306447A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
HK1013806A1 (en) Antibody purification
DK0906122T3 (da) Aktiverede linkers og fremgangsmåde til at fremstille og oprense disse
HK1031387A1 (en) Purification of molecules
BR9916101A (pt) Purificação de compostos de ciclopeptìdeos equinocandinos
DE69417617D1 (de) Kolonne für Flüssigkeitschromatographie
MX9707909A (es) Purificacion de anticuerpos.
AU3951589A (en) Peptide derivatives containing proline and leucine for use in affinity chromatography and a process for the preparation thereof
ZA944950B (en) Protein purification
DK75593D0 (xx)
AU4733293A (en) Purification of oxygen by cryogenic adsorption
AU6834294A (en) Metal chelates as spacer compounds in biologically active peptides
AU7466996A (en) An isolated and purified dna molecule and protein for the degradation of triazine compounds
PL346865A1 (en) Method for chromatographically purifying insulins
ZA934780B (en) A process for recovering a recombinant protein in biologically active from a solution containing inactive protein
EP0476875A3 (en) Process for the purification and concentration of biologically active materials
DK0833919T3 (da) Type F botulintoksin og anvendelse deraf
YU49889A (en) Process for affinity - chromatographic purifying of factor xiii
Basak et al. Affinity purification of proteinases by a combination of immobilized peptidyl aldehyde and semicarbazone
KR940005284A (ko) 면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법
DE69415664T2 (de) Methode zur trennung von glykosylierten und unglykosylierten proteinen
IT9047695A0 (it) Analizzatore automatico in cromatografia liquida ad elevata risoluzione (hplc) per il trattamento e la purificazione dei campioni e per la determinazione di sostanze in essi contenute.
HU9200507D0 (en) Novel method for the indentification of biologically active peptides from peptide mixtures in attacment-testing experiments
TW239078B (en) Pharmaceutical and veterinary composition for inhibiting metastasis
KR970009339B1 (en) Tpa from scolopendra subepinpes multilans and its purification method
PL266005A1 (en) System for column liquid chromatography and a column for purifying and stabilizing the mobile phase

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20181007